FEATURED TOP LISTS Follow us on twitter
AppAdvice AppAdvice/TV WatchAware

Haploscope is a tele-oncology mobile app that allows cancer patients and their caregivers to communicate with their oncologists and cancer clinics via virtual visits using in-app video conferences

Haploscope

by Haploscope Inc

What is it about?

Haploscope is a tele-oncology mobile app that allows cancer patients and their caregivers to communicate with their oncologists and cancer clinics via virtual visits using in-app video conferences. Cancer patients are able to accept virtual appointments from their physicians, manage their meeting schedules, and track their previous conversations. Patients are also able to communicate with their doctors using in-app messaging real time. Caregivers can join virtual appointments once invited by the patients. This app integrates three parties in a care management platform using tele-health services.

App Details

Version
1.0
Rating
(1)
Size
62Mb
Genre
Health & Fitness Medical
Last updated
March 30, 2022
Release date
March 30, 2022
More info

App Screenshots

App Store Description

Haploscope is a tele-oncology mobile app that allows cancer patients and their caregivers to communicate with their oncologists and cancer clinics via virtual visits using in-app video conferences. Cancer patients are able to accept virtual appointments from their physicians, manage their meeting schedules, and track their previous conversations. Patients are also able to communicate with their doctors using in-app messaging real time. Caregivers can join virtual appointments once invited by the patients. This app integrates three parties in a care management platform using tele-health services.

Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.